Form 4: HealthEquity Director Debra McCowan Receives Equity Grant of 2,003 Shares

HealthEquity, Inc. Director Debra McCowan acquired 2,003 shares of common stock through a restricted stock unit grant on June 26, 2025, increasing her total beneficial ownership to 9,782 shares.

Summary

• Debra Charlotte McCowan, a Director of HealthEquity, Inc. (HQY), acquired 2,003 shares of common stock.
• The acquisition occurred on June 26, 2025, and was reported on June 30, 2025.
• The shares were acquired at a price of $0, indicating a grant of restricted stock units (RSUs).
• Each restricted stock unit represents a contingent right to receive one share of HealthEquity's common stock.
• These restricted stock units are set to vest in full on the date of HealthEquity's next annual stockholder meeting.
• Following this transaction, Ms. McCowan beneficially owns a total of 9,782 shares of HealthEquity common stock.

Sentiment

Score: 7

Explanation: The transaction is a routine equity grant to an existing director, which is generally positive as it aligns interests, but it is not a direct cash investment or a significant market-moving event on its own. It reflects standard corporate compensation practices.

Positives

• Director McCowan's acquisition of 2,003 shares through an RSU grant aligns her interests with shareholders, demonstrating continued commitment to the company's long-term success.
• The grant of restricted stock units at a $0 price is a common form of equity compensation for directors, incentivizing long-term retention and performance.

Future Outlook

The vesting schedule for the restricted stock units, tied to the date of the next annual stockholder meeting, indicates a future event related to corporate governance and continued director service.

Industry Context

Insider transactions, particularly equity grants to directors, are standard practices across industries to align leadership interests with shareholder value. This specific transaction reflects HealthEquity's ongoing compensation practices for its board members, consistent with broader trends in corporate governance and executive remuneration.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) at a $0 price is a common and widely accepted form of non-cash compensation for directors in publicly traded companies, aligning with industry standards for executive and board remuneration.
• This method of compensation is prevalent among companies of similar size and market capitalization to HealthEquity, Inc., particularly within the healthcare technology and financial services sectors, as it incentivizes long-term commitment and performance.
• Comparable companies such as Optum, Inc. (a subsidiary of UnitedHealth Group), or other health savings account (HSA) providers and benefits administrators, often utilize similar equity-based compensation structures for their non-employee directors to foster alignment with shareholder interests.

Corporate Governance

Related Party Transactions

• The acquisition of 2,003 shares by Director Debra McCowan through a restricted stock unit grant is a related party transaction, representing a form of compensation from the company to a board member.

Stakeholder Impact

• Shareholders: The grant of restricted stock units to a director aligns board interests with shareholder value, potentially fostering long-term growth and stability by incentivizing the director's commitment to the company's performance.

Next Steps

• The 2,003 restricted stock units granted to Debra McCowan will vest in full on the date of HealthEquity's next annual stockholder meeting.
• Vested shares will be delivered to Debra McCowan upon vesting.

Key Dates

Recommendation

Keywords

HealthEquity, HQY, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Debra McCowan